Cargando…
miRNAs as Potential Biomarkers for Viral Hepatitis B and C
Around 257 million people are living with hepatitis B virus (HBV) chronic infection and 71 million with hepatitis C virus (HCV) chronic infection. Both HBV and HCV infections can lead to liver complications such as cirrhosis and hepatocellular carcinoma (HCC). To take care of these chronically infec...
Autores principales: | Loureiro, Dimitri, Tout, Issam, Narguet, Stéphanie, Benazzouz, Sabrina Menasria, Mansouri, Abdellah, Asselah, Tarik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765125/ https://www.ncbi.nlm.nih.gov/pubmed/33327640 http://dx.doi.org/10.3390/v12121440 |
Ejemplares similares
-
Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
por: Loureiro, Dimitri, et al.
Publicado: (2019) -
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis
por: Loureiro, Dimitri, et al.
Publicado: (2023) -
Highlights in Virology: Viral miRNAs and Flaviviruses
por: Banks, Lawrence
Publicado: (2019) -
Use of miRNAs as Biomarkers in Sepsis
por: Dumache, Raluca, et al.
Publicado: (2015) -
Plasma miRNAs as biomarkers for endometriosis
por: Vanhie, A, et al.
Publicado: (2019)